Treatment of Monosymptomatic Hypochondriacal Psychosis with Imipramine

F. Cashman,B. Pollock

DOI: https://doi.org/10.1177/070674378302800131

1983-02-01

Abstract:Dear Sir: Dr. Munro and Ms. Chmara (I) clearly outline in their article criteria for Monosymptomatic Hypochondriacal Psychosis. Riding and Munro's introduction of pimozide as an agent specific in the treatment of this condition has been beneficial in helping a difficult group of patients (2). However it should be remembered that there is not total agreement about the treatment of this disorder. Bishop cites the use of psychotherapy and has reported positively about its effect in MHP (3). Others suggest MHP is a variant of Affective Disorder and recommend a tricyclic and/ or ECT (4). A controlled trial using pimozide against a tricyclic, other neuroleptics or supportive psychotherapy has not yet been published. The following case demonstrates some of the problems in treatment. A forty-two year old man presented to the Emergency Room. He complained that he had "funny little legs with huge knobbly knees." He experienced severe pain in his legs. He had perceived his legs as deformed since he was fifteen. The pain was intermittent and for the previous few months had been severe. The patient stated he was depressed, had lost twenty pounds, was hypersomnic and lethargic. His wife agreed that his legs were strange looking. She was concerned about his pain. No physician had been able to find pathology in the legs and our examination could show no abnormality. The patient's belief was unaffected by our observations that his legs appeared normal. A diagnosis of Monosymptomatic Hypochondriacal Psychosis was made. Treatment was initiated with pimozide. Over the next 'week the patient had severe sideeffects. He demonstrated dystonia, akathisia and complained of a general sense of malaise which he attributed to the medication. The dose was decreased to the amount compatible with the least side-effects, and benztropine mesylate was introduced. The patient agreed to continue the pimozide at 4 mg per day for about three weeks. There was however little change in his delusional experience or his perception of painful legs.Pimozide was discontinued at the patient's insistence and imipramine was started at the physician's recommendation. In one week, on imipramine 150 mg per day the patient was much improved. In two weeks, he had no pain in his legs but still believed them to be slightly deformed. The latter thought rarely came into his mind and did not interfere with his work or his family life. At five months follow-up, the patient maintained this improvement. In reviewing this case wefelt that this patient met Munro's criteria for MHP. His depression, although severe, seemed secondary to his delusional experience. We expected a good response to pimozide and were disheartened by the notable